TRANSGENE BIOTEK LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 ,inter alia, to consider and approve 1) To consider and approve the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and half yearly ended on September 30, 2024.\r\n\r\n2) To consider and approve the Limited Review Report (Standalone & Consolidated) for the quarter and half yearly ended on ended September 30, 2024.\r\n\r\n3) To consider and approve the Notice of the 34th Annual General Meeting for the financial Year 2023-24 and other related matters thereto.\r\n\r\n4) To consider and approve Directors Report and the annexure thereon for the financial year 2023-24.\r\n\r\n5) To fix Record Date, Book Closure date and E voting dates etc.\r\n\r\n6) To Appoint a Scrutinizer for the e voting Process.\r\n\r\n7) To transact such other business as may be required.